Uncategorized French newspaper Le Figaro publishes El País iDR24 REMEDi4ALL article Nick Sireau was getting ready to change his newborn son's diaper when he discovered a…admin28 March 2024
NewsPatientsRare Diseases University College London publishes iDR24 conference report The UCL Translational Research Office led a UCL academic delegation to join the first international…admin27 March 2024
FundersNewsPatientsRare DiseasesResources Spanish newspaper El País attends iDR24 and publishes article on untapped potential of drug repurposing Exciting insights from #iDR24! Oriol Güell from El País explores the enormous potential of drug…admin11 March 2024
NewsPatients Alan Finglas Honoured with WORLDSymposium Patient Advocate Leader Award At the 20th Annual WORLD Symposium in San Diego this February, the global spotlight shone…Piret Baur21 February 2024
News Report Published on the Training Landscape for Drug Repurposing In March 2023, a Curriculum Setting Meeting took place to define what the REMEDi4ALL consortium…tools@teamitresearch.com18 January 2024
Resources NOW LIVE: the REMEDI4ALL Learning Resources database REMEDi4ALL has launched a learning resources database where you can find a whole host of…tools@teamitresearch.com10 January 2024
Demonstrator projectsNewsUncategorized REMEDi4ALL hosts first Multi-Stakeholder Meeting on Pancreatic Cancer Pancreatic cancer, a rare and hard to treat type of cancer, is one of four…tools@teamitresearch.com12 December 2023
Funders International Funders Network established A worldwide network of funders focusing on drug repurposing has been established under the leadership…tools@teamitresearch.com9 November 2023
News EATRIS and the REMEDi4ALL Consortium to Initiate New Study to Advance Potential Treatment for Ultra-Rare Disease Tazarotene, originally approved as a topical cream for psoriasis and acne, will be investigated as…admin13 October 2023
Resources REMEDi4ALL Concierge: Connecting with the drug repurposing community The primary objective of the REMEDi4ALL Concierge is to actively engage with the repurposing community,…Piret Baur28 September 2023
Uncategorized REMEDi4ALL General Assembly Meeting brings together over 100 participants to discuss roadmap ahead The second REMEDi4ALL General Assembly meeting took place in Amsterdam last June 26-27. Around 100 participants representing…tools@teamitresearch.com27 September 2023
Demonstrator projects First Patients Recruited in a Repurposing Clinical Trial Funded Through REMEDi4ALL Image: Alfredo Boudillon, Scientific Director of Institution Pascale Institute Pascale, a renowned comprehensive cancer centre…Piret Baur14 September 2023
Funders REMEDi4ALL’s first workshop for funders on Innovating drug repurposing Over 50 representatives from (non-) governmental funders, philanthropies and pharmaceutical companies from around the world…Piret Baur13 September 2023
Rare Diseases Rick Thompson on involving patients directly in creating impactful medicines Why is it that in drug development, the needs and preferences of those who are…Piret Baur8 September 2023
Rare Diseases EVE SCOTT: RARE DISEASE DAY, A PATIENT-LED COMMUNITY Please tell us a bit about yourself. I joined Beacon in October 2022 as Senior…Ivette Corominas27 February 2023
Rare Diseases CLAUDIA FUCHS: RARE DISEASE DAY IS A GLOBAL VOICE Please tell us a bit about yourself. I joined EURORDIS in September 2022 as part…Ivette Corominas22 February 2023
Rare Diseases RICK THOMPSON: RARE DISEASE DAY SHOWS A DETERMINED COMMUNITY Please tell us a bit about yourself. I’m the CEO of Beacon, formerly an evolutionary…Ivette Corominas15 February 2023
News Horizon Magazine highlights the innovative potential of drug repurposing , Horizon Magazine published an article on drug repurposing featuring REMEDi4ALL project. According to the…Ivette Corominas30 November 2022
News EURORDIS introduces REMEDi4ALL in an interview with Pharmaceutiques Virginie Hivert, Director of Therapeutic Development at Eurordis, was recently interviewed by PhamaceutiquesIvette Corominas30 November 2022
News Pancreatic Cancer Awareness Day: “Safe and effective therapies are urgently needed to fight Pancreatic Cancer” Every year, approximately 140.000 people are diagnosed with pancreatic cancer in Europe. This is one…Ivette Corominas17 November 2022